Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02918864 · ClinicalTrials.gov registry record · Phase 2
Oxytocin and Social Cognitive Skills Groups
A Phase 2 study, sponsored by Rush University Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 40
- Enrollment target
NCT02918864 is a Phase 2 study that has completed, run by Rush University Medical Center. The registered enrollment target is 40 participants.
The verdict
NCT02918864, a Phase 2 study, has completed, sponsored by Rush University Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the feasibility, safety, and preliminary efficacy of integrating targeted dosing of intranasal oxytocin with a social cognitive skills group therapy for school-aged children with autism spectrum disorder (ASD).
Interventions
- DRUG Oxytocin
- BEHAVIORAL Social Cognitive Skills Training
- BEHAVIORAL Facilitated Play Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2016-06-15 |
| Est. Completion | 2021-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02918864
The ClinicalTrials.gov registry entry for NCT02918864 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Oxytocin is the first listed.
NCT02918864 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02918864 about?
NCT02918864 is a clinical study titled "Oxytocin and Social Cognitive Skills Groups". The purpose of this study is to evaluate the feasibility, safety, and preliminary efficacy of integrating targeted dosing of intranasal oxytocin with a social cognitive skills group therapy for school-aged children with autism spectrum disorder (ASD).
What is the current status of trial NCT02918864?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2016-06-15. Estimated completion is 2021-09.
What interventions are being tested in trial NCT02918864?
The interventions under investigation include: Oxytocin (DRUG), Social Cognitive Skills Training (BEHAVIORAL), Facilitated Play Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT02918864?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.